Approval · Notice of Compliance 13775 · 2012
ZANAFLEX: Notice of Compliance 13775
Issued October 29, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13775
- Date
- October 29, 2012
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of drug substance source and change of manufacturing method
- Therapeutic class
- Antispastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANAFLEX | Not yet assigned | — |
Medicinal ingredients
- TIZANIDINE HCL 4 MG per TAB